Test Price
1,200 AED✅ Home Collection Available
BCR-ABL1 Quantification by Droplet Digital PCR (ddPCR) in UAE | 1200 AED | 2026 DHA Guidelines
تحليل BCR-ABL1 الكمي بتقنية التفاعل البوليميرازي المتسلسل الرقمي الدقيق في الإمارات | 1200 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: اختبار BCR-ABL1 الكمي بتقنية PCR الرقمي الدقيق (ddPCR) هو المعيار الذهبي لرصد عبء المرض الجزيئي لدى مرضى ابيضاض الدم النخاعي المزمن (CML) وابيضاض الأرومات الليمفاوية الحاد (ALL) إيجابي كروموسوم فيلادلفيا. يوفر حساسية تشخيصية استثنائية بنسبة 99.9% عبر مختبرنا المعتمد بموجب شهادة ISO 9001:2015 (رقم الشهادة: INT/EGQ/2509DA/3139)، مع خدمة سحب الدم المنزلي الفاخرة ضمن بيئة سلسلة تبريد معتمدة، واستشارة طبية هاتفية بعد صدور النتيجة لتفسيرها سريرياً وفق أحدث توجيهات هيئة الصحة بدبي لعام 2026.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified clinical counsellors.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview: BCR-ABL1 ddPCR Quantification
The BCR-ABL1 Quantification by Droplet Digital PCR (ddPCR) test measures the absolute copy number of the BCR-ABL1 fusion transcript in peripheral blood with unparalleled precision, enabling oncologists, hematologists, and preventive medicine specialists to monitor minimal residual disease (MRD) and assess tyrosine kinase inhibitor (TKI) therapy response at the molecular level. يقيس هذا الاختبار عدد نسخ جين الاندماج BCR-ABL1 في الدم المحيطي بدقة فائقة لمتابعة عبء المرض الجزيئي وتقييم الاستجابة لمثبطات التيروزين كيناز.
| Feature | Our Test: ddPCR | Closest Alternative: RT-qPCR |
|---|---|---|
| Precision & Sensitivity | Absolute quantification; detection down to 0.001% IS (MR4.5) | Relative quantification; typical limit ~0.01% IS (MR4.0) |
| Methodology | Droplet Digital PCR — partitions sample into ~20,000 nanodroplets for independent amplification | Real-Time Quantitative PCR — bulk reaction with standard curve dependency |
| Turnaround Time | 2–3 Days | 3–5 Days (variable) |
| Standardisation | Aligned to International Scale (IS) via WHO reference panel | IS conversion required; inter-laboratory variability higher |
| Price | 1200 AED | 900–1100 AED (estimated) |
Physician Insight & Safety Protocol
Clinical Note from Dr. Prabhakar Reddy — DHA License: 61713011, Specialist in Clinical Pathology & Molecular Diagnostics:
"The BCR-ABL1 ddPCR assay offers a transformative leap in molecular monitoring sensitivity, but I must emphasize that an isolated numerical result never replaces the full clinical picture. I advise every patient to review their ddPCR trend with their treating oncologist or hematologist — a single data point without clinical correlation, complete blood count, and physical examination may lead to misinterpretation. Treatment decisions, especially TKI dose adjustments or therapy discontinuation attempts, must always be guided by serial molecular monitoring and your physician's comprehensive assessment."
⚠ Medication Safety Warning
Do not discontinue, reduce, or modify your prescribed tyrosine kinase inhibitor (TKI) medication — including imatinib, dasatinib, nilotinib, bosutinib, ponatinib, or asciminib — without consulting your treating oncologist. Abrupt cessation of TKI therapy in patients with active molecular disease may precipitate blast crisis or relapsed acute leukemia, which constitute life-threatening medical emergencies requiring immediate hospitalization.
⚠ Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not validated for patients who have undergone allogeneic stem cell transplantation within the last 90 days (false-negative risk due to engraftment dynamics).
- Exclusion: Specimens with gross hemolysis (visual haemoglobin >500 mg/dL) will be rejected; repeat collection required.
- Emergency Red Flag: A >1-log increase in BCR-ABL1 transcript level between consecutive ddPCR assessments warrants urgent hematology-oncology consultation within 48 hours.
- Emergency Red Flag: New-onset fever, unexplained bruising, bone pain, or splenic discomfort in a known CML patient — seek emergency department evaluation immediately regardless of ddPCR result.
- Minors: Per UAE CDS Law 2026, testing on patients under 18 requires explicit parental or legal guardian consent with government-issued identification.
Patient FAQ & Clinical Guidance
Q: How is the BCR-ABL1 ddPCR test different from standard PCR, and why does it matter for my CML monitoring?
Droplet Digital PCR provides absolute quantification of BCR-ABL1 transcripts without requiring a standard curve, enabling detection of molecular relapse up to six months earlier than conventional RT-qPCR — this early warning allows your oncologist to intervene before hematological relapse occurs, directly impacting long-term treatment-free remission success rates. Unlike standard PCR which measures relative fluorescence against a calibration reference, ddPCR partitions your sample into ~20,000 individual nanodroplets where each droplet acts as an independent PCR reactor, counting positive versus negative droplets to deliver a precise copies-per-microliter result aligned to the WHO International Scale.
Q: What should I do to prepare for the blood draw, and are there any medications I need to temporarily hold?
No fasting is required for BCR-ABL1 ddPCR testing; however, you must continue all prescribed TKI medications exactly as directed — never withhold a dose for the purpose of this blood test, as the assay specifically measures the molecular response achieved while on therapy, and interrupting treatment would produce clinically misleading results that could jeopardize your care. A valid doctor's prescription is mandatory prior to sample collection. Please note: this test result alone is not a substitute for comprehensive pre-surgical clearance documentation, pregnancy-related clinical assessment, or international travel fitness certification.
س: كم من الوقت يستغرق ظهور النتيجة، وهل يمكنني الحصول على استشارة طبية بعد استلام التقرير؟
Your BCR-ABL1 ddPCR result is delivered within 2 to 3 working days via secure digital report, and every patient is entitled to a complimentary telephonic post- clinical guidance session where a qualified molecular diagnostics counsellor explains your IS percentage, log reduction milestone, and what the trend means in the context of your TKI therapy journey. تظهر نتيجة اختبار BCR-ABL1 بتقنية ddPCR خلال 2 إلى 3 أيام عمل عبر تقرير رقمي آمن، ويحق لكل مريض الحصول على جلسة استشارة طبية هاتفية مجانية بعد النتيجة لشرح النسبة المئوية وفق المقياس الدولي (IS) ومراحل الاستجابة الجزيئية ومدلولاتها في سياق رحلة العلاج بمثبطات التيروزين كيناز.
Regulatory Compliance & Data Privacy
Federal Decree-Law No. 41 of 2024
Full compliance with Article 87 governing clinical laboratory operations, diagnostic validity, and patient safety mandates within UAE healthcare facilities. All reporting adheres to DHA/MOHAP Standard Nomenclature.
CDS Law 2026 — Minor Protection
Strict adherence to consent requirements for patients under 18 years. Parental or legal guardian authorisation with valid Emirates ID or passport is mandatory prior to specimen collection.
UAE PDPL — Data Privacy
All patient genomic and molecular data is processed, stored, and transmitted in accordance with UAE Personal Data Protection Law. Results are encrypted end-to-end and accessible only to the ordering physician and authorised patient portal.
ISO 9001:2015 Certification: INT/EGQ/2509DA/3139 • DHA Facility License: 9834453 • LOINC: 69380-8 • 2026 ICD-10-CM: C92.10, C91.00, Z85.6
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians